Agilent Technologies, Inc. (A)
Market Cap | 34.94B |
Revenue (ttm) | 6.53B |
Net Income (ttm) | 1.26B |
Shares Out | 285.10M |
EPS (ttm) | 4.36 |
PE Ratio | 27.97 |
Forward PE | 21.49 |
Dividend | $0.99 (0.81%) |
Ex-Dividend Date | Apr 1, 2025 |
Volume | 59,930 |
Open | 122.60 |
Previous Close | 121.97 |
Day's Range | 121.89 - 123.00 |
52-Week Range | 117.17 - 155.35 |
Beta | 1.11 |
Analysts | Buy |
Price Target | 146.77 (+19.77%) |
Earnings Date | Feb 26, 2025 |
About A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry inst... [Read more]
Financial Performance
In 2024, Agilent Technologies's revenue was $6.51 billion, a decrease of -4.73% compared to the previous year's $6.83 billion. Earnings were $1.29 billion, an increase of 3.95%.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for A stock is "Buy." The 12-month stock price forecast is $146.77, which is an increase of 19.77% from the latest price.
News

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics' FDA approval for AUCATZYL®, a recently approved CAR T ther...

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE N...

Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is excited to announce its participation at the upcoming United States and Canadian Academy of Pathology (USCAP) Conference, w...

Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Columbia University has received an Agilent Research Catalyst (ARC) Award on behalf of Dr. Pawel Muranski...

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR1,...

Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)
Agilent Technologies, Inc. (NYSE:A) TD Cowen 45th Annual Healthcare Conference Call March 4, 2025 9:50 AM ET Company Participants Padraig McDonnell - Chief Executive Officer Bob McMahon - Chief Finan...

Agilent Technologies: Recent Price Weakness Makes This Stock A Buy
Agilent Technologies, a leader in life sciences and diagnostics, has a market cap of $38B and a 10-year CAGR of 13.6%. Key financial metrics: consistent revenue growth, stable gross profit margin abov...

Agilent to Participate in TD Cowen Health Care Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at TD Cowen's 45...

Agilent Technologies, Inc. (A) Q1 2025 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A) Q1 2025 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Parmeet Ahuja - Vice President of Investor Relations Padraig McDonnell - Preside...

Agilent lowers annual revenue forecast on soft demand for medical equipment
Medical equipment maker Agilent lowered its annual revenue forecast on Wednesday, as it expects soft demand for its medical tools and equipment from smaller biotech companies.

Agilent Reports First-Quarter Fiscal Year 2025 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, representing growth of 1.4% reported and up...

Agilent Announces Cash Dividend of 24.8 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on April 23...

Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2025 after the stock market closes on Wednesday, Feb. 26. ...

Agilent Automated Workflows at SLAS2025: Connecting with Confidence
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that it will feature new automated laboratory workflow solutions at the SLAS2025 International Conference & Ex...

Agilent Technologies, Inc. (A) J.P. Morgan 43rd Annual Healthcare Conference (Transcript)
Agilent Technologies, Inc. (NYSE:A) J.P. Morgan 43rd Annual Healthcare Conference January 14, 2025 12:45 PM ET Company Participants Padraig McDonnell - President and CEO Robert McMahon - Senior VP an...

Agilent Presents Solutions Innovation Research Awards to Aarhus University, University of Graz, and Imperial College London Scientists
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced Solutions Innovation Research Awards (SIRA) have been presented to Professor Anders Bentien of Aarhus Universi...

Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Bob McMahon will present at the 43rd Annual J.P. Morgan Healthcare Conferen...
Agilent CEO Padraig McDonnell sees 'long runway' in advancing therapeutics
Padraig McDonnell, Agilent CEO, joins 'Closing Bell Overtime' to talk investors day, its healthcare segment, and more.

Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 IH...

Agilent Q4: Expecting Market Recovery In 2025
I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic growth and market recovery. Agilent's acquisition of BIOVECTRA will enhance...

Agilent Technologies, Inc. (A) Q4 2024 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A) Q4 2024 Results Conference Call November 25, 2024 4:30 PM ET Company Participants Parmeet Ahuja - Vice President, Investor Relations Padraig McDonnell - President ...

Medical equipment maker Agilent's downbeat annual forecast clouds fourth-quarter beat
Agilent forecast its annual profit below analysts' estimates on Monday, as a recovery is ongoing in the market for medical tools and equipment used in clinical studies, sending its shares down more th...

Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.70 billion for the fourth quarter ended October 31, 2024, an increase of 0.8% reported and a decl...

Agilent Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Agilent Technologies, Inc. A will release earnings results for the fourth quarter, after the closing bell on Monday, Nov. 25.

Agilent Announces New Organizational Structure to Support its Market-Focused Strategy
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a new organizational structure to accelerate the company's operational transformation to drive higher growth t...